Global Blood Culture Tests Market Assessment & Opportunity Forecast till 2032

Comments · 244 Views

The global Blood Culture Tests Market is anticipated to grow at a high CAGR of 8.9% from 2023 to 2032.

According to a new report published by K D Market Insights, titled, “Blood Culture Test Market Insights, Trends, Opportunity Forecast, 2023–2032,” the global blood culture test market size is anticipated to witness moderate growth during the forecast period i.e., 2023-2032. The increasing prevalence of infectious diseases and the growing demand for early and accurate diagnosis. Blood culture tests play a crucial role in identifying and determining the presence of bacterial or fungal infections in the bloodstream which are the major factors augmenting the growth of the global blood culture test market.

The increasing prevalence of infectious diseases, including bloodstream infections, drives the demand for accurate and timely diagnosis are further expected to create ample growth opportunities for the global blood culture test market during the forecast period i.e., 2023-2032. Moreover, rise in the geriatric population, is increasing has propelled market expansion. There is a surge in demand for diagnostic tests, including blood culture tests, is expected to contribute towards the market growth during the period.

The North America region accounted for the largest share in the global blood culture test market in 2022. The region is further projected to continue dominating in the market and also register the highest CAGR in the market during the forecast period. This can be attributed to the significant presence of blood culture test providers in this region, including well-established diagnostic laboratories and healthcare facilities.

According to method, the conventional methods segment accounted for the largest market share in the blood culture test market in 2022 and is further expected to continue with the trend during the forecast period i.e., 2023 – 2032.

The global blood culture test market is segmented into method, product, technology, application, end user and region. Based on method, the market is bifurcated into conventional methods and automated methods. Based on product, it is classified into consumables, instruments and software and services. Based on technology, it is classified into culture-based technology, molecular technologies and proteomics technology. Based on application, it is classified into bacteraemia, fungaemia and mycobacterial detection. Based on end user, it is classified into hospital laboratories, reference laboratories, academic research laboratories and other.

The global blood culture test market is analyzed across North America (U.S. Canada), Europe (Germany, United Kingdom, France, Italy, Spain, Russia, and Rest of Europe), Asia Pacific (China, India, Japan, South Korea, Indonesia, Thailand, Australia, New Zealand, and Rest of Asia Pacific), Latin America (Brazil, Mexico, and the Rest of Latin America) and Middle East Africa (GCC (Saudi Arabia, UAE, Bahrain, Kuwait, Qatar, Oman), North Africa, South Africa, and Rest of Middle East Africa).

Key Insights of Blood Culture Test Market

  • On the basis of method, the conventional methods segment accounted for the largest market share in the blood culture test market in 2022 and is further expected to continue with the trend during the forecast period i.e., 2023 – 2032.
  • On the basis of region, North America accounted for the largest share in the global blood culture test market in 2022. The region is further projected to continue dominating in the market during the forecast period.
  • On the basis of region, Europe is estimated to account for the second largest share in the market during the forecast period.

Some of the major blood culture test companies profiled in the report include Becton, Dickinson and Company, bioMérieux SA, Thermo Fisher Scientific Inc., Luminex Corporation, Danaher Corporation, Bruker Corporation, IRIDICA, Roche Diagnostics, T2 Biosystems, Inc., Anaerobe Systems, Inc., OpGen, Inc., Meditech Technologies India Private Limited, Carl Zeiss AG, Nikon Corporation, BINDER GmbH, Biobase Biotech Co., Ltd., Scenker Biological Technology Co., Ltd., Bulldog Bio, Inc., Axiom Laboratories, and HiMedia Laboratories Pvt. Ltd.

Related Reports :-

https://www.kdmarketinsights.com/reports/drug-repurposing-market/7354

https://www.kdmarketinsights.com/reports/compression-therapy-market/7353

https://www.kdmarketinsights.com/reports/cervical-implants-market/7352

https://www.kdmarketinsights.com/reports/antibody-library-technologies-market/7328

Comments